{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:01:50Z","timestamp":1795089710727,"version":"4.10.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930108"],"award-info":[{"award-number":["81930108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"DOI":"10.1038\/s44161-023-00313-y","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T16:01:32Z","timestamp":1691424092000},"page":"764-777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Deubiquitinase JOSD2 improves calcium handling and attenuates cardiac hypertrophy and dysfunction by stabilizing SERCA2a in cardiomyocytes"],"prefix":"10.1038","volume":"2","author":[{"given":"Jibo","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozhi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wante","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaojun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-0092","authenticated-orcid":false,"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8278-849X","authenticated-orcid":false,"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"key":"313_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura, M. & Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol. 15, 387\u2013407 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"313_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrd2193","volume":"6","author":"TA McKinsey","year":"2007","unstructured":"McKinsey, T. A. & Kass, D. A. Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface. Nat. Rev. Drug Discov. 6, 617\u2013635 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"313_CR3","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1111\/jcmm.14330","volume":"23","author":"K Yan","year":"2019","unstructured":"Yan, K., Wang, K. & Li, P. The role of post-translational modifications in cardiac hypertrophy. J. Cell. Mol. Med. 23, 3795\u20133807 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"313_CR4","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic, D., Vucic, D. & Dikic, I. Ubiquitination in disease pathogenesis and treatment. Nat. Med. 20, 1242\u20131253 (2014).","journal-title":"Nat. Med."},{"key":"313_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","volume":"86","author":"TET Mevissen","year":"2017","unstructured":"Mevissen, T. E. T. & Komander, D. Mechanisms of deubiquitinase specificity and regulation. Annu. Rev. Biochem. 86, 159\u2013192 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"313_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41569-019-0331-x","volume":"17","author":"E Karbassi","year":"2020","unstructured":"Karbassi, E. et al. Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine. Nat Rev. Cardiol. 17, 341\u2013359 (2020).","journal-title":"Nat Rev. Cardiol."},{"key":"313_CR7","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3389\/fphar.2020.01311","volume":"11","author":"C Zeng","year":"2020","unstructured":"Zeng, C. et al. Machado\u2013Joseph deubiquitinases: from cellular functions to potential therapy targets. Front. Pharmacol. 11, 1311 (2020).","journal-title":"Front. Pharmacol."},{"key":"313_CR8","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/molbev\/mst022","volume":"30","author":"AP Hutchins","year":"2013","unstructured":"Hutchins, A. P., Liu, S., Diez, D. & Miranda-Saavedra, D. The repertoires of ubiquitinating and deubiquitinating enzymes in eukaryotic genomes. Mol. Biol. Evol. 30, 1172\u20131187 (2013).","journal-title":"Mol. Biol. Evol."},{"key":"313_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0022-510X(95)90927-I","volume":"132","author":"G Haberhausen","year":"1995","unstructured":"Haberhausen, G., Damian, M. S., Leweke, F. & M\u00fcller, U. Spinocerebellar ataxia, type 3 (SCA3) is genetically identical to Machado\u2013Joseph disease (MJD). J. Neurol. Sci. 132, 71\u201375 (1995).","journal-title":"J. Neurol. Sci."},{"key":"313_CR10","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/j.celrep.2017.05.067","volume":"19","author":"B Zhang","year":"2017","unstructured":"Zhang, B. et al. PHGDH defines a metabolic subtype in lung adenocarcinomas with poor prognosis. Cell Rep. 19, 2289\u20132303 (2017).","journal-title":"Cell Rep."},{"key":"313_CR11","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/s41418-020-00639-1","volume":"28","author":"L Krassikova","year":"2021","unstructured":"Krassikova, L. et al. The deubiquitinase JOSD2 is a positive regulator of glucose metabolism. Cell Death Differ. 28, 1091\u20131109 (2021).","journal-title":"Cell Death Differ."},{"key":"313_CR12","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1016\/j.apsb.2021.04.003","volume":"11","author":"M Qian","year":"2021","unstructured":"Qian, M. et al. Deubiquitinase JOSD2 stabilizes YAP\/TAZ to promote cholangiocarcinoma progression. Acta Pharm. Sin. B 11, 4008\u20134019 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"313_CR13","doi-asserted-by":"publisher","unstructured":"Huang, Y. et al. Deubiquitinating enzyme JOSD2 promotes hepatocellular carcinoma progression through interacting with and inhibiting CTNNB1 degradation. Cell Biol. Int. https:\/\/doi.org\/10.1002\/cbin.11812 (2022).","DOI":"10.1002\/cbin.11812"},{"key":"313_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40164-022-00295-w","volume":"11","author":"H Lei","year":"2022","unstructured":"Lei, H. et al. JOSD2 regulates PKM2 nuclear translocation and reduces acute myeloid leukemia progression. Exp. Hematol. Oncol. 11, 42 (2022).","journal-title":"Exp. Hematol. Oncol."},{"key":"313_CR15","first-page":"100011","volume":"3","author":"KC Grasty","year":"2019","unstructured":"Grasty, K. C., Weeks, S. D. & Loll, P. J. Structural insights into the activity and regulation of human Josephin-2. J. Struct. Biol. X 3, 100011 (2019).","journal-title":"J. Struct. Biol. X"},{"key":"313_CR16","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.111.259754","volume":"110","author":"EG Kranias","year":"2012","unstructured":"Kranias, E. G. & Hajjar, R. J. Modulation of cardiac contractility by the phospholamban\/SERCA2a regulatome. Circ. Res. 110, 1646\u20131660 (2012).","journal-title":"Circ. Res."},{"key":"313_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10741-019-09873-3","volume":"25","author":"L Zhihao","year":"2020","unstructured":"Zhihao, L. et al. SERCA2a: a key protein in the Ca2+ cycle of the heart failure. Heart Fail. Rev. 25, 523\u2013535 (2020).","journal-title":"Heart Fail. Rev."},{"key":"313_CR18","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1161\/CIRCRESAHA.111.252981","volume":"110","author":"L Tilemann","year":"2012","unstructured":"Tilemann, L., Ishikawa, K., Weber, T. & Hajjar, R. J. Gene therapy for heart failure. Circ. Res. 110, 777\u2013793 (2012).","journal-title":"Circ. Res."},{"key":"313_CR19","doi-asserted-by":"publisher","unstructured":"Sitsel, A. et al. Structures of the heart specific SERCA2a Ca2+-ATPase. EMBO J. https:\/\/doi.org\/10.15252\/embj.2018100020 (2019).","DOI":"10.15252\/embj.2018100020"},{"key":"313_CR20","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1161\/CIRCULATIONAHA.119.040747","volume":"141","author":"Y Fan","year":"2020","unstructured":"Fan, Y. et al. Phosphoproteomic analysis of neonatal regenerative myocardium revealed important roles of checkpoint kinase 1 via activating mammalian target of rapamycin C1\/ribosomal protein S6 kinase b-1 pathway. Circulation 141, 1554\u20131569 (2020).","journal-title":"Circulation"},{"key":"313_CR21","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1161\/HYPERTENSIONAHA.116.07392","volume":"67","author":"B He","year":"2016","unstructured":"He, B. et al. Ubiquitin-specific protease 4 is an endogenous negative regulator of pathological cardiac hypertrophy. Hypertension 67, 1237\u20131248 (2016).","journal-title":"Hypertension"},{"key":"313_CR22","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/HYPERTENSIONAHA.116.07562","volume":"68","author":"X Ying","year":"2016","unstructured":"Ying, X. et al. Novel protective role for ubiquitin-specific protease 18 in pathological cardiac remodeling. Hypertension 68, 1160\u20131170 (2016).","journal-title":"Hypertension"},{"key":"313_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/HYPERTENSIONAHA.110.149963","volume":"56","author":"H Huang","year":"2010","unstructured":"Huang, H. et al. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-b-activated kinase 1-dependent signaling. Hypertension 56, 232\u2013239 (2010).","journal-title":"Hypertension"},{"key":"313_CR24","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nature10407","volume":"477","author":"C Kho","year":"2011","unstructured":"Kho, C. et al. SUMO1-dependent modulation of SERCA2a in heart failure. Nature 477, 601\u2013605 (2011).","journal-title":"Nature"},{"key":"313_CR25","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/HYPERTENSIONAHA.118.11357","volume":"72","author":"J Ye","year":"2018","unstructured":"Ye, J. et al. Programmed cell death 5 provides negative feedback on cardiac hypertrophy through the stabilization of sarco\/endoplasmic reticulum Ca2+-ATPase 2a protein. Hypertension 72, 889\u2013901 (2018).","journal-title":"Hypertension"},{"key":"313_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.119.12998","volume":"74","author":"B Cai","year":"2019","unstructured":"Cai, B. et al. Long noncoding RNA\u2013DACH1 (dachshund homolog 1) regulates cardiac function by inhibiting SERCA2a (sarcoplasmic reticulum calcium ATPase 2a). Hypertension 74, 833\u2013842 (2019).","journal-title":"Hypertension"},{"key":"313_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/CIRCRESAHA.113.302421","volume":"114","author":"K Zsebo","year":"2014","unstructured":"Zsebo, K. et al. Long-term effects of AAV1\/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality. Circ. Res. 114, 101\u2013108 (2014).","journal-title":"Circ. Res."},{"key":"313_CR28","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","volume":"387","author":"B Greenberg","year":"2016","unstructured":"Greenberg, B. et al. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial. Lancet 387, 1178\u20131186 (2016).","journal-title":"Lancet"},{"key":"313_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaci.2020.09.003","volume":"147","author":"L Zhou","year":"2021","unstructured":"Zhou, L. et al. Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease development. J. Allergy Clin. Immunol. 147, 267\u2013279 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"313_CR30","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1161\/HYPERTENSIONAHA.122.20004","volume":"79","author":"J Han","year":"2022","unstructured":"Han, J. et al. GSDMD (gasdermin D) mediates pathological cardiac hypertrophy and generates a feed-forward amplification cascade via mitochondria\u2013STING (stimulator of interferon genes) axis. Hypertension 79, 2505\u20132518 (2022).","journal-title":"Hypertension"},{"key":"313_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.trsl.2022.05.001","volume":"248","author":"B Ye","year":"2022","unstructured":"Ye, B. et al. Gasdermin D mediates doxorubicin-induced cardiomyocyte pyroptosis and cardiotoxicity via directly binding to doxorubicin and changes in mitochondrial damage. Transl. Res. 248, 36\u201350 (2022).","journal-title":"Transl. Res."},{"key":"313_CR32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.309202","volume":"119","author":"M Ackers-Johnson","year":"2016","unstructured":"Ackers-Johnson, M. et al. A simplified, Langendorff-free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart. Circ. Res. 119, 909\u2013920 (2016).","journal-title":"Circ. Res."}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00313-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00313-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00313-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T23:05:21Z","timestamp":1691708721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00313-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["313"],"URL":"https:\/\/doi.org\/10.1038\/s44161-023-00313-y","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,7]]},"assertion":[{"value":"12 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}